![Boris Warnack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Boris Warnack
Keine laufenden Positionen mehr
Karriereverlauf von Boris Warnack
Ehemalige bekannte Positionen von Boris Warnack
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Xeltis AG
![]() Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Geschäftsführer | - | 01.10.2018 |
Ausbildung von Boris Warnack
University of Kassel | Graduate Degree |
Statistik
International
Schweiz | 2 |
Deutschland | 2 |
Operativ
Chief Operating Officer | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Xeltis AG
![]() Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
- Börse
- Insiders
- Boris Warnack
- Erfahrung